FANTA BERETAY: Open Payments
NPI 1801045695 · GROVE CITY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$916 in 36 payments from 6 companies in 2025. Trend: 2023 $859 · 2024 $289 · 2025 $916
Food & beverage: $916
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 11 | $349 |
| Alkermes, Inc. | 13 | $295 |
| ABBVIE INC. | 4 | $96 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $88 |
| Supernus Pharmaceuticals, Inc. | 3 | $62 |
| Janssen Pharmaceuticals, Inc | 1 | $25 |
Products named: Auvelity, ARISTADA, VRAYLAR, CAPLYTA, Qelbree, SPRAVATO.
Industry payments across OH — which companies pay providers there.
